Future Fund LLC’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
142,007
+46,886
+49% +$3.2M 3.19% 1
2026
Q1
$6.15M Buy
95,121
+12,091
+15% +$852K 2.16% 3
2025
Q4
$5.59M Buy
83,030
+20,581
+33% +$1.38M 1.77% 5
2025
Q3
$4.58M Buy
62,449
+6,757
+12% +$449K 1.62% 5
2025
Q2
$2.9M Buy
55,692
+21,873
+65% +$1.24M 1.29% 12
2025
Q1
$2.16M Buy
33,819
+16,223
+92% +$942K 2.77% 6
2024
Q4
$841K Buy
17,596
+6,500
+59% +$333K 2.4% 20
2024
Q3
$634K Sell
11,096
-25,199
-69% -$1.44M 1.83% 27
2024
Q2
$1.89M Buy
36,295
+24,020
+196% +$1.05M 4.74% 4
2024
Q1
$499K Buy
12,275
+5,109
+71% +$192K 4.05% 10
2023
Q4
$265K Sell
7,166
-1,400
-16% -$52.7K 0.73% 27
2023
Q3
$327K Sell
8,566
-596
-7% -$24.4K 0.91% 14
2023
Q2
$330K Buy
+9,162
New +$313K 3.14% 17

Other funds holding HALO

Future Fund LLC's HALO Position: Q2 2026 in Review

Future Fund LLC increased its Halozyme (HALO) stake by 49% in Q2 2026, buying an estimated $3.2M and bringing the position to 142,007 shares worth $11.1M. The position accounts for 3.19% of the portfolio, ranked #1.

Future Fund LLC first reported a position in HALO in Q2 2023 and has held it in 13 quarters since. 670 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Future Fund LLC held 142,007 shares of Halozyme worth $11.1M as of Q2 2026.
  • Future Fund LLC bought 46,886 Halozyme shares in Q2 2026, an estimated $3.2M.
  • Halozyme made up 3.19% of Future Fund LLC's portfolio in Q2 2026, its #1 holding.
  • Future Fund LLC first reported a position in Halozyme in Q2 2023 and has held it in 13 quarters since.
  • 670 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Future Fund LLC's 13F filing for Q2 2026, filed 12 Aug 2026.